HMGCR and neoplasm: However, when combined with PD-1 blockade, it did trigger ferroptosis in immune-refractory tumor cells, suggesting that HMGCR inhibition primes tumor cells for ferroptosis, which is subsequently activated during T cell-mediated immune attack facilitated by PD-1 blockade.